Alternative lengthening of telomeres in human glioma stem cells.
about
Intratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid stateGenetic Inactivation of ATRX Leads to a Decrease in the Amount of Telomeric Cohesin and Level of Telomere Transcription in Human Glioma CellsTelomere Length Maintenance and Cardio-Metabolic Disease Prevention Through Exercise Training.A cell-penetrating peptide based on the interaction between c-Src and connexin43 reverses glioma stem cell phenotype.Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas.Crosstalk between telomere maintenance and radiation effects: A key player in the process of radiation-induced carcinogenesis.The anti-hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ-dependent inhibition of the AKT pathway.Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells.Wnt activation is implicated in glioblastoma radioresistance.PML-mediated signaling and its role in cancer stem cells.Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT).Human cancer growth and therapy in immunodeficient mouse models.Connective-Tissue Growth Factor (CTGF/CCN2) Induces Astrogenesis and Fibronectin Expression of Embryonic Neural Cells In Vitro.Expression of telomeres in astrocytoma WHO grade 2 to 4: TERRA level correlates with telomere length, telomerase activity, and advanced clinical grade.Selective increase in subtelomeric DNA methylation: an epigenetic biomarker for malignant gliomaA model of a patient-derived IDH1 mutant anaplastic astrocytoma with alternative lengthening of telomeresTelomeres and Telomerase in the Radiation Response: Implications for Instability, Reprograming, and Carcinogenesis.Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age.Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide.A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in gliomaTelomerase-independent paths to immortality in predictable cancer subtypes.Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies.Telomerase as a "stemness" enzyme.A glioblastoma neurosphere line with alternative lengthening of telomeresTelomeres and telomerase in prostate cancer development and therapy.Subventricular zone-associated glioblastoma: A call for translational research to guide clinical decision making.Opposite effects of GCN5 and PCAF knockdowns on the alternative mechanism of telomere maintenance.Sirtuin-2 activity is required for glioma stem cell proliferation arrest but not necrosis induced by resveratrol.Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.Sphere-Induced Rejuvenation of Swine and Human Müller Glia Is Primarily Caused by Telomere Elongation.Radiosensitization Effect of Talazoparib, a Parp Inhibitor, on Glioblastoma Stem Cells Exposed to Low and High Linear Energy Transfer Radiation.Differential proteomic analysis of human glioblastoma and neural stem cells reveals HDGF as a novel angiogenic secreted factor.Quiescence status of glioblastoma stem-like cells involves remodelling of Ca2+ signalling and mitochondrial shape.Alkaloids from Rutaceae: activities of canthin-6-one alkaloids and synthetic analogues on glioblastoma stems cells
P2860
Q27334127-50EBE4EF-C71B-4E96-BA93-87C53EFDF0B0Q28118722-E78B806F-EE50-42BD-B20A-E61F3B4F155FQ30251870-32456CD5-90B0-417D-A819-62C992349347Q30579545-9C2BBEE1-1AB6-43AD-90B2-EB5197B97C4BQ33737472-63927F51-31A7-445C-BF08-9EBB515CA49CQ33990112-8BF2482E-5BC1-4632-AED1-0CC6253DC240Q34046737-C1FF3673-3697-41F4-8BE3-422CFDE38701Q34076281-1B262C8A-7FF8-4973-AB2A-48F0844869A2Q34232635-76EC87CA-5D27-4B46-B9A8-23CBC50CE9A6Q34337626-E5BA5341-3C7C-4582-9ED3-5FDCF435939AQ34665512-80BE82CE-B139-4AC7-AFA8-667A5162185BQ35004395-67DA327E-BA6F-4AF2-8D13-D205C87FFE1BQ35545282-7CFDE4D9-A70D-4F8B-B3E7-EEF17E0A49E0Q35737521-A6CEB81B-9EC1-47DC-BB94-1A6DB68B5C1CQ35762230-E7B2149C-1192-4EBE-9AE1-3D84749C11BEQ36135415-1FE5A70B-7E8A-4C1A-9D33-7A7883829CFFQ36288179-40731C5E-A14C-4E97-A29A-9215DAB4E4DEQ36309657-03F6049C-5CEE-457C-9656-67438855A170Q36713512-ABB68106-C6FB-44E5-89DB-77B884EE296EQ37148255-2B5D586A-D10C-4A60-A9E3-D6BB80814367Q37697462-4D10BDC3-D24D-4143-AF3F-BA68A48022A5Q37982375-336C5407-0195-4B41-B30C-96CC697E97BCQ38066416-540A9FB7-3921-4712-BF0A-DFE845B06D3CQ38211826-B1B01E34-A1D1-46AB-92B7-1F4AB99A50BFQ39097642-D93175F6-3BAF-4D33-A826-59FEE25478ADQ39413214-A5E3E86F-F69A-4887-94EB-82EB802CD394Q41894296-86046707-CC74-4D60-A50B-CC99FB790171Q42265703-16ACFA3D-34F8-41E5-9C66-6F8D498241D0Q47753685-EBB581B4-EEA0-485E-8BF4-2502871BE4FDQ47964508-3EB17BF5-72DA-43BB-9BD6-C7E20C7A0F5EQ47978822-B2E91402-237F-4C73-9CC8-A3926CB7A915Q51747262-B0770187-E84C-43DF-9943-90808A75E28CQ55462273-6B0B4F27-A0ED-45EF-820C-63070D10D1E7Q55513476-40AAB20E-1CD3-4A41-99C5-25723C586652Q58848739-115EB9BD-AB29-44C5-8150-9DCF191248D8
P2860
Alternative lengthening of telomeres in human glioma stem cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Alternative lengthening of telomeres in human glioma stem cells.
@en
Alternative lengthening of telomeres in human glioma stem cells.
@nl
type
label
Alternative lengthening of telomeres in human glioma stem cells.
@en
Alternative lengthening of telomeres in human glioma stem cells.
@nl
prefLabel
Alternative lengthening of telomeres in human glioma stem cells.
@en
Alternative lengthening of telomeres in human glioma stem cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
Alternative lengthening of telomeres in human glioma stem cells
@en
P2093
David C Silvestre
Françoise Hoffschir
Jeanne-Marie Studler
Marie-Pierre Junier
P2860
P304
P356
10.1002/STEM.600
P577
2011-03-01T00:00:00Z